Found 36 Enz. Inhib. hit(s) with Target = 'Voltage-dependent L-type calcium channel subunit alpha-1C/L-type calcium channel subunit beta-1/calcium channel subunit alpha-2/delta-1'
TargetVoltage-dependent L-type calcium channel subunit alpha-1C/L-type calcium channel subunit beta-1/calcium channel subunit alpha-2/delta-1(Homo sapiens (Human))
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 610nMAssay Description:Inhibition of L type calcium channel alpha-1c/alpha-2-delta-1/beta-1b expressed in HEK293 cells in presence of -100 mV holding potential by whole-cel...More data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit alpha-1C/L-type calcium channel subunit beta-1/calcium channel subunit alpha-2/delta-1(Homo sapiens (Human))
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 1.03E+3nMAssay Description:Inhibition of L type calcium channel alpha-1c/alpha-2-delta-1/beta-1b expressed in HEK293 cells in presence of -100 mV holding potential by whole-cel...More data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit alpha-1C/L-type calcium channel subunit beta-1/calcium channel subunit alpha-2/delta-1(Homo sapiens (Human))
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 1.10E+3nMAssay Description:Inhibition of L-type calcium channel alpha-1c/alpha-2-delta-1/beta-1b expressed in HEK293 cells by FLIPR methodMore data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit alpha-1C/L-type calcium channel subunit beta-1/calcium channel subunit alpha-2/delta-1(Homo sapiens (Human))
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 1.10E+3nMAssay Description:Inhibition of L-type calcium channel alpha-1c/alpha-2-delta-1/beta-1b expressed in HEK293 cells by FLIPR methodMore data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit alpha-1C/L-type calcium channel subunit beta-1/calcium channel subunit alpha-2/delta-1(Homo sapiens (Human))
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 1.40E+3nMAssay Description:Inhibition of L-type calcium channel alpha-1c/alpha-2-delta-1/beta-1b expressed in HEK293 cells by FLIPR methodMore data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit alpha-1C/L-type calcium channel subunit beta-1/calcium channel subunit alpha-2/delta-1(Homo sapiens (Human))
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 1.40E+3nMAssay Description:Inhibition of L-type calcium channel alpha-1c/alpha-2-delta-1/beta-1b expressed in HEK293 cells by FLIPR methodMore data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit alpha-1C/L-type calcium channel subunit beta-1/calcium channel subunit alpha-2/delta-1(Homo sapiens (Human))
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 1.60E+3nMAssay Description:Inhibition of L-type calcium channel alpha-1c/alpha-2-delta-1/beta-1b expressed in HEK293 cells by FLIPR methodMore data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit alpha-1C/L-type calcium channel subunit beta-1/calcium channel subunit alpha-2/delta-1(Homo sapiens (Human))
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 1.60E+3nMAssay Description:Inhibition of L-type calcium channel alpha-1c/alpha-2-delta-1/beta-1b expressed in HEK293 cells by FLIPR methodMore data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit alpha-1C/L-type calcium channel subunit beta-1/calcium channel subunit alpha-2/delta-1(Homo sapiens (Human))
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 1.80E+3nMAssay Description:Inhibition of L-type calcium channel alpha-1c/alpha-2-delta-1/beta-1b expressed in HEK293 cells by FLIPR methodMore data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit alpha-1C/L-type calcium channel subunit beta-1/calcium channel subunit alpha-2/delta-1(Homo sapiens (Human))
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 1.84E+3nMAssay Description:Inhibition of L type calcium channel alpha-1c/alpha-2-delta-1/beta-1b expressed in HEK293 cells in presence of -100 mV holding potential by whole-cel...More data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit alpha-1C/L-type calcium channel subunit beta-1/calcium channel subunit alpha-2/delta-1(Homo sapiens (Human))
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 2.50E+3nMAssay Description:Inhibition of L-type calcium channel alpha-1c/alpha-2-delta-1/beta-1b expressed in HEK293 cells by FLIPR methodMore data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit alpha-1C/L-type calcium channel subunit beta-1/calcium channel subunit alpha-2/delta-1(Homo sapiens (Human))
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 2.90E+3nMAssay Description:Inhibition of L-type calcium channel alpha-1c/alpha-2-delta-1/beta-1b expressed in HEK293 cells by FLIPR methodMore data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit alpha-1C/L-type calcium channel subunit beta-1/calcium channel subunit alpha-2/delta-1(Homo sapiens (Human))
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 2.90E+3nMAssay Description:Inhibition of L-type calcium channel alpha-1c/alpha-2-delta-1/beta-1b expressed in HEK293 cells by FLIPR methodMore data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit alpha-1C/L-type calcium channel subunit beta-1/calcium channel subunit alpha-2/delta-1(Homo sapiens (Human))
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 3.10E+3nMAssay Description:Inhibition of L-type calcium channel alpha-1c/alpha-2-delta-1/beta-1b expressed in HEK293 cells by FLIPR methodMore data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit alpha-1C/L-type calcium channel subunit beta-1/calcium channel subunit alpha-2/delta-1(Homo sapiens (Human))
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 3.50E+3nMAssay Description:Inhibition of L-type calcium channel alpha-1c/alpha-2-delta-1/beta-1b expressed in HEK293 cells by FLIPR methodMore data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit alpha-1C/L-type calcium channel subunit beta-1/calcium channel subunit alpha-2/delta-1(Homo sapiens (Human))
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 3.80E+3nMAssay Description:Inhibition of L-type calcium channel alpha-1c/alpha-2-delta-1/beta-1b expressed in HEK293 cells by FLIPR methodMore data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit alpha-1C/L-type calcium channel subunit beta-1/calcium channel subunit alpha-2/delta-1(Homo sapiens (Human))
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 4.30E+3nMAssay Description:Inhibition of L type calcium channel alpha-1c/alpha-2-delta-1/beta-1b expressed in HEK293 cells in presence of -100 mV holding potential by whole-cel...More data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit alpha-1C/L-type calcium channel subunit beta-1/calcium channel subunit alpha-2/delta-1(Homo sapiens (Human))
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 6.10E+3nMAssay Description:Inhibition of L-type calcium channel alpha-1c/alpha-2-delta-1/beta-1b expressed in HEK293 cells by FLIPR methodMore data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit alpha-1C/L-type calcium channel subunit beta-1/calcium channel subunit alpha-2/delta-1(Homo sapiens (Human))
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 6.20E+3nMAssay Description:Inhibition of L-type calcium channel alpha-1c/alpha-2-delta-1/beta-1b expressed in HEK293 cells by FLIPR methodMore data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit alpha-1C/L-type calcium channel subunit beta-1/calcium channel subunit alpha-2/delta-1(Homo sapiens (Human))
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 6.60E+3nMAssay Description:Inhibition of L type calcium channel alpha-1c/alpha-2-delta-1/beta-1b expressed in HEK293 cells in presence of -100 mV holding potential by whole-cel...More data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit alpha-1C/L-type calcium channel subunit beta-1/calcium channel subunit alpha-2/delta-1(Homo sapiens (Human))
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 6.80E+3nMAssay Description:Inhibition of L-type calcium channel alpha-1c/alpha-2-delta-1/beta-1b expressed in HEK293 cells by FLIPR methodMore data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit alpha-1C/L-type calcium channel subunit beta-1/calcium channel subunit alpha-2/delta-1(Homo sapiens (Human))
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 6.90E+3nMAssay Description:Inhibition of L-type calcium channel alpha-1c/alpha-2-delta-1/beta-1b expressed in HEK293 cells by FLIPR methodMore data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit alpha-1C/L-type calcium channel subunit beta-1/calcium channel subunit alpha-2/delta-1(Homo sapiens (Human))
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 7.40E+3nMAssay Description:Inhibition of L-type calcium channel alpha-1c/alpha-2-delta-1/beta-1b expressed in HEK293 cells by FLIPR methodMore data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit alpha-1C/L-type calcium channel subunit beta-1/calcium channel subunit alpha-2/delta-1(Homo sapiens (Human))
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 7.90E+3nMAssay Description:Inhibition of L-type calcium channel alpha-1c/alpha-2-delta-1/beta-1b expressed in HEK293 cells by FLIPR methodMore data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit alpha-1C/L-type calcium channel subunit beta-1/calcium channel subunit alpha-2/delta-1(Homo sapiens (Human))
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 8.50E+3nMAssay Description:Inhibition of L type calcium channel alpha-1c/alpha-2-delta-1/beta-1b expressed in HEK293 cells in presence of -100 mV holding potential by whole-cel...More data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit alpha-1C/L-type calcium channel subunit beta-1/calcium channel subunit alpha-2/delta-1(Homo sapiens (Human))
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 8.60E+3nMAssay Description:Inhibition of L-type calcium channel alpha-1c/alpha-2-delta-1/beta-1b expressed in HEK293 cells by FLIPR methodMore data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit alpha-1C/L-type calcium channel subunit beta-1/calcium channel subunit alpha-2/delta-1(Homo sapiens (Human))
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 9.30E+3nMAssay Description:Inhibition of L-type calcium channel alpha-1c/alpha-2-delta-1/beta-1b expressed in HEK293 cells by FLIPR methodMore data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit alpha-1C/L-type calcium channel subunit beta-1/calcium channel subunit alpha-2/delta-1(Homo sapiens (Human))
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 9.60E+3nMAssay Description:Inhibition of L-type calcium channel alpha-1c/alpha-2-delta-1/beta-1b expressed in HEK293 cells by FLIPR methodMore data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit alpha-1C/L-type calcium channel subunit beta-1/calcium channel subunit alpha-2/delta-1(Homo sapiens (Human))
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of L-type calcium channel alpha-1c/alpha-2-delta-1/beta-1b expressed in HEK293 cells by FLIPR methodMore data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit alpha-1C/L-type calcium channel subunit beta-1/calcium channel subunit alpha-2/delta-1(Homo sapiens (Human))
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 1.10E+4nMAssay Description:Inhibition of L type calcium channel alpha-1c/alpha-2-delta-1/beta-1b expressed in HEK293 cells in presence of -100 mV holding potential by whole-cel...More data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit alpha-1C/L-type calcium channel subunit beta-1/calcium channel subunit alpha-2/delta-1(Homo sapiens (Human))
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 1.22E+4nMAssay Description:Inhibition of L type calcium channel alpha-1c/alpha-2-delta-1/beta-1b expressed in HEK293 cells in presence of -100 mV holding potential by whole-cel...More data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit alpha-1C/L-type calcium channel subunit beta-1/calcium channel subunit alpha-2/delta-1(Homo sapiens (Human))
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 1.79E+4nMAssay Description:Inhibition of L type calcium channel alpha-1c/alpha-2-delta-1/beta-1b expressed in HEK293 cells in presence of -100 mV holding potential by whole-cel...More data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit alpha-1C/L-type calcium channel subunit beta-1/calcium channel subunit alpha-2/delta-1(Homo sapiens (Human))
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 1.96E+4nMAssay Description:Inhibition of L type calcium channel alpha-1c/alpha-2-delta-1/beta-1b expressed in HEK293 cells in presence of -100 mV holding potential by whole-cel...More data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit alpha-1C/L-type calcium channel subunit beta-1/calcium channel subunit alpha-2/delta-1(Homo sapiens (Human))
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 3.00E+4nMAssay Description:Inhibition of L type calcium channel alpha-1c/alpha-2-delta-1/beta-1b expressed in HEK293 cells in presence of -100 mV holding potential by whole-cel...More data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit alpha-1C/L-type calcium channel subunit beta-1/calcium channel subunit alpha-2/delta-1(Homo sapiens (Human))
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 1.00E+5nMAssay Description:Inhibition of L type calcium channel alpha-1c/alpha-2-delta-1/beta-1b expressed in HEK293 cells in presence of -100 mV holding potential by whole-cel...More data for this Ligand-Target Pair
TargetVoltage-dependent L-type calcium channel subunit alpha-1C/L-type calcium channel subunit beta-1/calcium channel subunit alpha-2/delta-1(Homo sapiens (Human))
Neuromed Pharmaceuticals
Curated by ChEMBL
Neuromed Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 1.06E+5nMAssay Description:Inhibition of L type calcium channel alpha-1c/alpha-2-delta-1/beta-1b expressed in HEK293 cells in presence of -100 mV holding potential by whole-cel...More data for this Ligand-Target Pair